All Stories

  1. Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

    Article • Biologics Targets and Therapy, May 2019, Dove Medical Press

    Dr Farhad Salehzadeh, Dr. Farhad Salehzadeh, Omid Ghanbarpour